Cresco Labs (OTC: CRLBF) , a Chicago-based cannabis multi-state operator (MSO), announced in March that it was acquiring Columbia Care (OTC: CCHWF) , a similar cannabis MSO, in an estimated $2 billion deal that is expected to close by the end of this year. After gobbling up Columbia Care, here's why Cresco Labs may become the farthest-reaching, most profitable cannabis company in the U.S.
Taken together, both companies' recently announced Q2 results could foretell what the new Cresco Labs earnings look like come the New year .
Cresco posted total sales of $218 million in Q2 2022, up 4% year over year. Its gross revenue was $112 million, up 5.1% sequentially and 11.7% year over year.
For further details see:
Cresco Labs Gets Closer to Its Massive Deal With Columbia Care